ArticleInfection2026

The efficacy and safety of omadacycline plus β-lactam versus moxifloxacin plus β-lactam for the treatment of severe community-acquired pneumonia: study protocol of a multicenter, prospective, randomized controlled non-inferiority trial.

Xin Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.